Farmacosmo S.p.A. (BIT:COSMO)
Italy · Delayed Price · Currency is EUR 0.4800
+0.0110 (2.35%)
Last updated: Jul 27, 2026, 11:23 AM CET
Farmacosmo Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -4.6 | -3.07 | -3.93 | -1.66 | 0.41 |
Depreciation & Amortization | 2.65 | 2.63 | 2.83 | 1.1 | 0.42 |
Other Adjustments | 2.69 | -0.13 | 0.12 | -0.12 | 0.06 |
Change in Receivables | 2.12 | 1.25 | 0.36 | -0.91 | -0.55 |
Changes in Inventories | 1.49 | -1.93 | -2.6 | -1.27 | -1.1 |
Changes in Accounts Payable | -0.21 | -1.67 | -2.59 | 2.66 | 0.77 |
Changes in Accrued Expenses | -0.12 | -0.06 | -0.11 | 0.35 | 0.07 |
Changes in Other Operating Activities | -3.47 | 0.86 | 0.75 | -0.31 | -0.37 |
Operating Cash Flow | 0.55 | -2.13 | -5.18 | -0.16 | -0.28 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.02 | -0.05 | -0.11 | -0.11 | -0.15 |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0 | - | - |
Purchases of Intangible Assets | -2.7 | -1.19 | -1.8 | -3.16 | -0.67 |
Proceeds from Sale of Intangible Assets | 0.8 | 0.24 | 0.06 | - | - |
Purchases of Investments | -0.09 | 0.02 | - | -10.27 | -0.07 |
Proceeds from Sale of Investments | - | - | 0.5 | - | - |
Proceeds from Business Divestments | - | 0.51 | - | - | - |
Investing Cash Flow | -2 | -0.45 | -1.34 | -13.54 | -0.89 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | -0.83 | 1.47 | 4.49 | -0.23 | 0.14 |
Net Short-Term Debt Issued (Repaid) | -0.83 | 1.47 | 4.49 | -0.23 | 0.14 |
Long-Term Debt Issued | 1.8 | 1 | 0.57 | - | 0.38 |
Long-Term Debt Repaid | -1 | -1.83 | -0.33 | -0.1 | - |
Net Long-Term Debt Issued (Repaid) | 0.8 | -0.83 | 0.25 | -0.1 | 0.38 |
Issuance of Common Stock | - | - | - | 2.94 | 0 |
Net Common Stock Issued (Repurchased) | - | - | - | 2.94 | 0 |
Common Dividends Paid | - | - | - | 15.5 | - |
Other Financing Activities | -0.7 | - | - | - | - |
Financing Cash Flow | -0.73 | 0.64 | 4.74 | 18.11 | 0.52 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -2.17 | -1.94 | -1.79 | 4.4 | -0.65 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.53 | -2.18 | -5.29 | -0.27 | -0.43 |
Free Cash Flow Growth | - | - | - | - | - |
FCF Margin | 1.01% | -3.42% | -7.29% | -0.40% | -0.73% |
Free Cash Flow Per Share | 0.01 | -0.06 | -0.14 | -0.01 | -6.25 |
Levered Free Cash Flow | -4.14 | -2.56 | -0.33 | 0.75 | 0.58 |
Unlevered Free Cash Flow | -7.06 | -2.48 | -4.89 | 0.89 | 0.32 |